Aller au contenu principal
Profil bibliographique

Alexander Büchner

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

388Publications signalées
6416Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Bladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrinary and Genital Oncology StudiesUrinary Bladder and Prostate Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy

Can Daniel Aydogdu, Benso John, Clara Seizer, Frederik Kolligs et autres

Background and objective: High-risk prostate cancer (PCa) carries substantial risks of recurrence, metastasis, and mortality. Neoadjuvant therapy before radical prostatectomy (RP) remains investigational. The PROTEUS (NCT03767244) trial evaluates perioperative apalutamide + androgen deprivation therapy (ADT) but lacks a surgery-only control cohort. The …

de (code pays fourni par la source)

0 citations European Urology Open Science
Accès ouvert 2026 article OpenAlex

PSA density for clinically significant prostate cancer detection: a retrospective cohort study on the influence of age and prostate volume

Lucas Engelage, Niklas Behnel, Agron Lumiani, Oleksii Bashkanov et autres

PURPOSE: PSA density (PSAD) may improve detection of clinically significant prostate cancer (csPCa) by normalizing PSA for prostate volume. Current practice applies a uniform PSAD threshold of 0.15 ng/ml/cm³; however, whether this approach performs adequately across prostate volumes remains unclear. This study …

fr, de (code pays fourni par la source)

1 citation World Journal of Urology
Accès ouvert 2026 article OpenAlex

Radical Prostatectomy Without Prior Biopsy? Final Histopathology of Radical Prostatectomies in 103 Consecutive Biopsy-naïve Patients Who Underwent Radical Prostatectomy

Marie Semmler, Julian Marcon, Elena K Berg, Gerald B. Schulz et autres

BACKGROUND AND OBJECTIVE: Prostate biopsy for histological confirmation is the standard before radical prostatectomy (RP). However, some patients refuse biopsy despite highly suspicious imaging findings. This study aimed to evaluate final pathology, assess potential active surveillance (AS) eligibility, and exploratorily evaluate perioperative …

de, au, ch (code pays fourni par la source)

0 citations European Urology Focus
2026 article OpenAlex

Transition Zone PSA Density Does Not Improve Detection of Clinically Significant Prostate Cancer over Whole-Gland PSA Density: A Volume-Stratified Analysis in 3,958 Patients

Niklas Behnel, Lucas Engelage, Agron Lumiani, Alexander Büchner et autres

INTRODUCTION: Transition zone PSA density (TZ-PSAD) was proposed to improve prostate cancer detection by normalizing PSA to the compartment most affected by benign prostatic hyperplasia (BPH). If valid, TZ-PSAD should provide the greatest benefit in large prostates where BPH predominates. We tested …

de (code pays fourni par la source)

0 citations Urologia Internationalis
Accès ouvert 2026 conference-paper OpenAlex

Onkologische Ergebnisse in einer „PROTEUS-ähnlichen“ Kohorte von Hochrisiko-Prostatakarzinomen, die mittels radikaler Prostatektomie ohne perioperative Hormontherapie behandelt wurden

Thilo Westhofen, Alexander Büchner, Frederik Kolligs, Iason Papadopoulos et autres

Einleitung: Hochrisiko-Prostatakarzinome sind mit einem hohen Risiko für Rezidive, Metastasierung und Mortalität verbunden. Neoadjuvante systemische Therapien vor radikaler Prostatektomie (RP) gelten weiterhin als experimentelll. Die PROTEUS-Studie untersucht eine perioperative Behandlung [zum vollständigen Text gelangen Sie über die oben angegebene URL]

de (code pays fourni par la source)

0 citations German Medical Science (German Research Foundation)
Accès ouvert 2026 article OpenAlex

Combining 5-ALA-PDT with berbamine as an in vitro multimodal therapy approach against bladder cancer cells

Muriel Kabus, Maximilian Aumiller, Adrain Rühm, Thomas Pongratz et autres

Bladder cancer is a common urogenital malignancy that remains difficult to treat, particularly due to therapeutic resistance, such as resistance to cisplatin, in which cancer stem cells (CSCs) play a central role. This study investigates the combination of 5-aminolevulinic acid-mediated photodynamic therapy …

de (code pays fourni par la source)

0 citations Scientific Reports
Accès ouvert 2025 article OpenAlex

Investigations on MRI changes after 5-aminolevulinic acid mediated interstitial photodynamic therapy for malignant gliomas

Mohamed El Fahim, Marco Foglar, Herbert G. Stepp, Alexander Büchner et autres

The treatment of glioblastoma still faces challenges due to poor prognosis, necessitating alternative therapies such as interstitial photodynamic therapy (iPDT). Using oral 5-ALA administration and stereotactic light application, iPDT aims to cause a selective, phototoxic effect to the tumor cells. To gain …

de (code pays fourni par la source)

1 citation Photochemical & Photobiological Sciences
Accès ouvert 2025 article OpenAlex

Comparison of PSA Values from capillary dried blood spot analysis and venous serum samples

Lucas Engelage, Niklas Behnel, Agron Lumiani, Alexander J. Tamalunas et autres

Prostate-specific antigen (PSA) testing is a key tool in the early detection and monitoring of prostate cancer. While venous blood is the standard matrix for PSA measurement, capillary blood sampling represents a minimally invasive alternative that may facilitate broader access to testing. …

de (code pays fourni par la source)

1 citation PLoS ONE

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.